Breakthrough treatment for pancreatic cancer doubles survival rates
January 25, 2017Research and Development CRUK, Cancer Research UK, Pancreatic cancer
Research led by Liverpool University and funded by Cancer Research UK has shown that a combination treatment of two off-patent …
Indian pharma firm caught shredding documents at 1am by FDA
January 24, 2017Manufacturing and Production, Research and Development FDA, Hetero Labs, observations
Hetero Labs, an Indian pharmaceutical firm, has been observed by the FDA shredding what the FDA judged to be controlled …
Pharmafocus January/February is now live!
January 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, digital edition
Inside this issue…
EMA Accelerated Assessment for AbbVie’s hepatitis C regimen
January 24, 2017Manufacturing and Production, Research and Development AbbVie, EMA, hepatitis C
AbbVie has announced that its investigational, pan-genotypic regimen of Glecaprevir/Pibrentasvir has been awarded Accelerated Assessment by the European Medicines Agency …
US Pharma launches multi-million dollar media campaign to deflect pricing criticism
January 24, 2017Manufacturing and Production, Medical Communications PhMRA, Trump
In response to a number of recent criticisms over pricing including president Trump’s message that pharma companies are “getting away …
Roche’s Actemra granted Priority Review by FDA
January 24, 2017Manufacturing and Production, Sales and Marketing Actemra, FDA, Roche, priority review
Roche’s drug, Actemra (also known as RoActemra in Europe), has been granted priority review designation by the FDA for the …
Thinking big data
January 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, IBM Watson Health, ibm
The potential solutions offered by ‘big data’ seems to offer a vision of the future but potential solutions aren’t enough …
Rival to EpiPen to be made available to many for free
January 23, 2017Manufacturing and Production, Sales and Marketing Kaleo, Mylan, epipen, rival
Mylan has been under scrutiny over its pricing policy with its branded EpiPen; the pressure told and led to them …
CEPI backed by Bill Gates raises funds to combat epidemics
January 23, 2017Medical Communications, Sales and Marketing Bill & Melinda Gates foundation, Bill Gates, CEPI
CEPI, the Coalition for Epidemic Preparedness Innovations, have launched the beginning of its fundraising initiative – with the aim of …
Leaflets offering gold coins for paediatricians appear at Bengaluru event
January 23, 2017Medical Communications, Sales and Marketing India, PEDICON
Pharmaceutical firms in India are not allowed to offer any kind of reimbursement for privileging certain treatment over others, this …
Artificial skin development has implications for clinical trials
January 23, 2017Medical Communications, Sales and Marketing Seoul National University Hospital, artificial skin, dermatology
Researchers from Seoul National University Hospital have announced that it has developed a microchip that has been designed to replicate …
BMS receives $625 million patent settlement boost from Merck
January 23, 2017Sales and Marketing BMS, MSD, Merck, keytruda, opdivo
Bristol-Myers Squibb were in desperate need of releasing good news after the brief announcement that it would no longer be …
Company in 85,000% infant epilepsy drug price increase receives $100 million fine
January 23, 2017Sales and Marketing Mallinckrodt, Martin Skhreli
Mallinckrodt Pharmaceuticals has hit the headlines for particularly dispiriting reasons – with further evidence of practise by some companies that …
Asia-Pacific flu market to hit $1.71bn by 2022
January 20, 2017Business Services, Medical Communications APAC, GBI Research
According to new data from intelligence provider GBI Research, the flu vaccines market in the Asia-Pacific (APAC) region is set …
“Biggest leap in decades” for prostate cancer, 1 in 4 could avoid biopsies
January 20, 2017Medical Communications, Research and Development Biposy, prostate cancer
A new study has estimated that one in four men could avoid unnecessary invasive biopsies to detect prostate cancer – …
J&J’s Imbruvica scores fifth FDA lymphoma approval
January 20, 2017Medical Communications, Research and Development, Sales and Marketing FDA, Marginal Zone Lymphoma, imbruvica
Johnson & Johnson’s Imbruvica (ibrutinib) has scored its fifth indication approval in the US for the treatment of Marginal Zone …
Top Ten most popular articles on Pharmafile.com this week
January 20, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s Friday, and there have been some big revelations for the pharma industry this week. Brexit, the ever-present hot topic …
Pharmaceutical R&D tax credit regulatory legislation: The need for clarity
January 20, 2017Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile
Since their introduction in the UK in 2000, R&D tax credits have provided a significant boost to pharmaceutical and biotech …
Sanofi diabetes drug Sulinqua green-lighted in Europe
January 19, 2017Research and Development, Sales and Marketing Sanofi, Sulinqua
Sanofi’s diabetes drug Suliqua has been granted marketing authorisation by the European Commission, giving the go ahead for the launch …
Boehringer steps into Humira race with US and EU biosimilar filings
January 19, 2017Sales and Marketing Boehringer Ingelheim, Humira, biosimilar
Boehringer Ingelheim has just stepped into the ring to battle it out for a slice of Humira’s revenue with accepted …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
